News
PMCPA News
Press releases appear below, filter by date.
28 May 10:00 – 12:00: PMCPA webinar on forthcoming 2021 Code of Practice – for those not able to attend the series of webinars for pharmaceutical companies
Press release: 27 April 2021
28 May 10:00 – 12:00: PMCPA webinar on forthcoming 2021 Code of Practice – for those not able to attend the series of webinars for pharmaceutical companies
Consultation on Amendments to the Agreed 2021 ABPI Code
Press release: 24 March 2021
Consultation on Amendments to the Agreed 2021 ABPI Code
Camurus, Accord, Swedish Orphan Biovitrum (Sobi), Strides Pharma, Boehringer Ingelheim, Vifor Pharma, GlaxoSmithKline and Sintetica named in advertisements for breaches of the ABPI Code
Press release: 02 March 2021
Camurus, Accord, Swedish Orphan Biovitrum (Sobi), Strides Pharma, Boehringer Ingelheim, Vifor Pharma, GlaxoSmithKline and Sintetica named in advertisements for breaches of the ABPI Code
The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 and changes to and impact on the 2019 ABPI Code of Practice for the Pharmaceutical Industry
Press release: 16 February 2021
The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 and changes to and impact on the 2019 ABPI Code of Practice for the Pharmaceutical Industry
Updates to prescribing information for centrally approved medicines and other medicines from 1 January 2021
Press release: 16 February 2021
Updates to prescribing information for centrally approved medicines and other medicines from 1 January 2021
Vifor Pharma, Napp, Otsuka Europe, Otsuka UK , Teva UK, Bayer, Janssen, Merck Serono, Britannia, Novo Nordisk, Rayner and Shionogi Europe named in advertisements for breaches of the ABPI Code
Press release: 01 February 2021
Forthcoming 2021 ABPI Code
Press release: 15 January 2021
New Chair of the Code of Practice Appeal Board
Press release: 11 December 2020
Colonis Pharma has been named in advertisements for breaches of ABPI Code.
Press release: 25 September 2020
Merck Sharp & Dohme, Gilead Sciences Europe, Daiichi-Sankyo and Allergan have been named in advertisements for breaches of ABPI Code.
Press release: 25 September 2020
Pfizer and Bristol Myers Squibb, The Alliance, named in advertisements for breaches of the ABPI Code of Practice
Press release: 25 September 2020
PMCPA launches search for a new Chair of the Code of Practice Appeal Board
Press release: 05 August 2020